DRUG · Mapped RxNorm record
Glucagon
Normalized identity: glucagonView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
NCT03091673
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedGlucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
GlucagonDRUG · verified · RxNorm: glucagon
Sponsors & collaborators
Xeris Pharmaceuticalslead sponsor
The Emmes Company, LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03091673 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.